Article
Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
International journal of radiation oncology, biology, physics - 1 Feb 2023
Li Li, Sun Jujie, Liu Ning, Yu Ruoying, Zhang Junli, Pang Jiaohui, Ou Qiuxiang, Yin Ying, Cui Jinfeng, Yao Xuling, Zhao Ranran, Shao Yang, Yuan Shuanghu, Yu Jinming
Abstract excerpt
PURPOSE: Definitive chemoradiotherapy (dCRT) is a standard-of-care for locally advanced unresectable esophageal squamous cell carcinoma (ESCC). However, even in individuals treated with the same dCRT regimen, differences in the local control rate and radiation-induced thoracic toxicity exist (radiation-induced esophagitis [RIE]). METHODS AND MATERIALS: Here, we describe a comprehensive genomic evaluation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
